104 related articles for article (PubMed ID: 18802996)
21. Hematopoietic stem cell gene therapy.
Emery DW; Nishino T; Murata K; Fragkos M; Stamatoyannopoulos G
Int J Hematol; 2002 Apr; 75(3):228-36. PubMed ID: 11999349
[TBL] [Abstract][Full Text] [Related]
22. Noninvasive gene delivery to foveal cones for vision restoration.
Khabou H; Garita-Hernandez M; Chaffiol A; Reichman S; Jaillard C; Brazhnikova E; Bertin S; Forster V; Desrosiers M; Winckler C; Goureau O; Picaud S; Duebel J; Sahel JA; Dalkara D
JCI Insight; 2018 Jan; 3(2):. PubMed ID: 29367457
[TBL] [Abstract][Full Text] [Related]
23. Critical assessment of lifelong phenotype correction in hyperbilirubinemic Gunn rats after retroviral mediated gene transfer.
Nguyen TH; Aubert D; Bellodi-Privato M; Flageul M; Pichard V; Jaidane-Abdelghani Z; Myara A; Ferry N
Gene Ther; 2007 Sep; 14(17):1270-7. PubMed ID: 17611583
[TBL] [Abstract][Full Text] [Related]
24. Delivery of Adeno-Associated Virus Gene Therapy by Intravascular Limb Infusion Methods.
Gruntman AM; Flotte TR
Hum Gene Ther Clin Dev; 2015 Sep; 26(3):159-64. PubMed ID: 26357010
[TBL] [Abstract][Full Text] [Related]
25. Targeting EGFR with metabolically biotinylated fiber-mosaic adenovirus.
Pereboeva L; Komarova S; Roth J; Ponnazhagan S; Curiel DT
Gene Ther; 2007 Apr; 14(8):627-37. PubMed ID: 17251987
[TBL] [Abstract][Full Text] [Related]
26. A new player in gene therapy for pain?
Pohl M; Fink DJ
Gene Ther; 2008 Jul; 15(13):953-4. PubMed ID: 18463685
[No Abstract] [Full Text] [Related]
27. The genetic immunodeficiency disease, leukocyte adhesion deficiency, in humans, dogs, cattle, and mice.
Gu YC; Bauer TR; Ackermann MR; Smith CW; Kehrli ME; Starost MF; Hickstein DD
Comp Med; 2004 Aug; 54(4):363-72. PubMed ID: 15357315
[TBL] [Abstract][Full Text] [Related]
28. Foamy virus--adenovirus hybrid vectors.
Picard-Maureau M; Kreppel F; Lindemann D; Juretzek T; Herchenröder O; Rethwilm A; Kochanek S; Heinkelein M
Gene Ther; 2004 Apr; 11(8):722-8. PubMed ID: 14724670
[TBL] [Abstract][Full Text] [Related]
29. Foamy virus-adenovirus hybrid vectors for gene therapy of the arthritides.
Weber C; Armbruster N; Scheller C; Kreppel F; Kochanek S; Rethwilm A; Steinert AF
J Gene Med; 2013; 15(3-4):155-67. PubMed ID: 23554302
[TBL] [Abstract][Full Text] [Related]
30. Cytokines: value-added products in hematopoietic stem cell gene therapy.
Zielske SP; Braun SE
Mol Ther; 2004 Aug; 10(2):211-9. PubMed ID: 15294167
[No Abstract] [Full Text] [Related]
31. Gene therapy for primary immune deficiencies.
Otsu M; Wada T; Candotti F
Curr Opin Allergy Clin Immunol; 2001 Dec; 1(6):497-501. PubMed ID: 11964732
[TBL] [Abstract][Full Text] [Related]
32. Evidence for the in vivo safety of insulated foamy viral vectors.
Browning DL; Everson EM; Leap DJ; Hocum JD; Wang H; Stamatoyannopoulos G; Trobridge GD
Gene Ther; 2017 Mar; 24(3):187-198. PubMed ID: 28024082
[TBL] [Abstract][Full Text] [Related]
33. Transductional targeting of adenovirus vectors for gene therapy.
Glasgow JN; Everts M; Curiel DT
Cancer Gene Ther; 2006 Sep; 13(9):830-44. PubMed ID: 16439993
[TBL] [Abstract][Full Text] [Related]
34. Comparative biology of rAAV transduction in ferret, pig and human airway epithelia.
Liu X; Luo M; Guo C; Yan Z; Wang Y; Engelhardt JF
Gene Ther; 2007 Nov; 14(21):1543-8. PubMed ID: 17728794
[TBL] [Abstract][Full Text] [Related]
35. A foamy virus vector system for stable and efficient RNAi expression in mammalian cells.
Papadaki M; Siapati EK; Vassilopoulos G
Hum Gene Ther; 2011 Oct; 22(10):1293-303. PubMed ID: 21456885
[TBL] [Abstract][Full Text] [Related]
36. Protective role of NF-kappaB in liver cold ischemia/reperfusion injury: effects of IkappaB gene therapy.
Takahashi Y; Ganster RW; Ishikawa T; Okuda T; Gambotto A; Shao L; Murase N; Geller DA
Transplant Proc; 2001; 33(1-2):602. PubMed ID: 11266976
[No Abstract] [Full Text] [Related]
37. Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector.
Oka K; Belalcazar LM; Dieker C; Nour EA; Nuno-Gonzalez P; Paul A; Cormier S; Shin JK; Finegold M; Chan L
Gene Ther; 2007 Feb; 14(3):191-202. PubMed ID: 16957769
[TBL] [Abstract][Full Text] [Related]
38. Modified infusion procedures affect recombinant adeno-associated virus vector type 2 transduction in the liver.
Ohashi K; Nakai H; Couto LB; Kay MA
Hum Gene Ther; 2005 Mar; 16(3):299-306. PubMed ID: 15812225
[TBL] [Abstract][Full Text] [Related]
39. Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome.
Lodde BM; Mineshiba F; Wang J; Cotrim AP; Afione S; Tak PP; Baum BJ
Ann Rheum Dis; 2006 Feb; 65(2):195-200. PubMed ID: 15975969
[TBL] [Abstract][Full Text] [Related]
40. Foamy virus vectors.
Mergia A; Heinkelein M
Curr Top Microbiol Immunol; 2003; 277():131-59. PubMed ID: 12908771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
